|Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2012 Financial Results|
Menlo Park, Calif., March 5, 2013 - Geron Corporation (Nasdaq: GERN) will announce its financial results for the fourth quarter and year ended December 31, 2012, on Tuesday, March 12, 2013, after the market close. Geron's management will host a conference call for analysts and investors on Wednesday, March 13, 2013, at 9:00 a.m. Eastern Time to discuss the company's fourth quarter and annual results and highlights.
Participants can access the conference call live via telephone by dialing 866-270-6057 (U.S.); 617-213-8891 (international). The passcode is 80790305. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/3328hz6w/lan/en. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through April 12, 2013.
Geron is a biopharmaceutical company developing first-in-class therapies for cancer, including its telomerase inhibitor, imetelstat, in clinical development. For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
|RSS Feeds | E-mail Alerts | Financial Tear Sheet|